Janus kinase (JAK) inhibitor

TOFACT
  • Rheumatoid arthritis (moderate–severe)
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Ulcerative colitis (moderate–severe)
  • Juvenile idiopathic arthritis
  • Under study: alopecia, vitiligo

Janus kinase (JAK) inhibitor

TOFACT

OHM Insights

View Detail

OHM INSIGHT 24th issue
View Detail

OHM INSIGHT 23nd Issue
View Detail

OHM INSIGHTS- 22th Issue
View Detail

OHM INSIGHT 21st ISSUE